IFF reports flat 2024 sales of $11.48 billion; Q4 net loss of $0.18 per share
International Flavors & Fragrances reported fourth quarter and full year 2024 results on February 18, 2025. Full year reported EPS was $0.95 versus a loss of $10.05 in 2023, which included a $2.6 billion goodwill impairment, while fourth quarter reported EPS was a loss of $0.18 on fourth quarter sales up 3% to $2.77 billion. For 2025 the company guided to sales of $10.6 billion to $10.9 billion and adjusted operating EBITDA of $2 billion to $2.15 billion, with the Pharma Solutions divestiture assumed to close June 30, 2025.
Key points
- Full year 2024 reported sales were $11.48 billion, flat versus 2023; comparable currency neutral sales rose 6%.
- Full year 2024 reported EPS was $0.95 versus a loss of $10.05 in 2023; adjusted EPS excluding amortization was $4.31.
- Fourth quarter 2024 reported loss before taxes was $(115) million; reported EPS was $(0.18).
- 2025 guidance: sales of $10.6 billion to $10.9 billion and adjusted operating EBITDA of $2 billion to $2.15 billion.
The filing
Written by AI on Nov 8, 2026, 12:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 18, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.